Physician

Denis B Fitzgerald, M.D.

According to 2025 Medicare claims, Denis Fitzgerald, M.D. (NPI: 1265427223) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07739-1166.

Fitzgerald's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,033 traditional Medicare patients, billed 186,159 HCPCS/CPT codes, and received $4,589,160 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,681 prescription claims across 330 beneficiaries totaling $6,130,006 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 233 claims. Open Payments data shows 10 records totaling $3,523. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $3,136,489 to $6,130,006. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,446 to $11,386.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,038	192,018	$3,115,191
2016	1,055	230,856	$3,582,239
2017	1,038	231,930	$3,804,018
2018	922	159,845	$3,581,692
2019	890	161,180	$4,181,443
2020	801	169,459	$4,378,785
2021	855	187,062	$4,498,056
2022	947	184,523	$4,901,692
2023	982	169,811	$4,503,576
2024	1,033	186,159	$4,589,160

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	307	1,764	$3,136,489
2016	331	1,876	$3,774,887
2017	321	1,818	$4,107,473
2018	332	1,840	$5,217,179
2019	342	1,948	$6,029,079
2020	338	1,936	$6,083,312
2021	327	1,722	$5,651,724
2022	323	1,636	$4,801,812
2023	310	1,640	$5,891,116
2024	330	1,681	$6,130,006

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	414	$109,195
2016	37	337	$67,277
2017	N/R	378	$32,567
2018	N/R	164	$13,425
2019	N/R	99	$6,086
2020	N/R	151	$10,237
2021	N/R	37	$3,170
2022	N/R	96	$2,568
2023	N/R	90	$5,634
2024	N/R	233	$12,267

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	507	1,451	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	412	582	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	306	673	$13
36415	Insertion of needle into vein for collection of blood sample	828	2,028	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	861	2,430	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	53	1,484	$886,790
Revlimid	Lenalidomide	44	1,232	$778,386
Brukinsa	Zanubrutinib	51	1,530	$758,440
Xtandi	Enzalutamide	30	900	$417,291
Stelara	Ustekinumab	13	752	$397,259

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	35	$7,107
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	59	$2,168
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	58	$1,151
J9190	Injection, fluorouracil, 500 mg	N	N/R	59	$1,090
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$562

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$3,523	BeiGene USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Denis B. Fitzgerald, M.D.?

Tedicare shows public-source Medicare data for Denis B. Fitzgerald, M.D. (NPI 1265427223), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Denis B. Fitzgerald, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Denis B. Fitzgerald, M.D.?

Denis B. Fitzgerald, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Denis B. Fitzgerald, M.D. have Open Payments data?

Denis B. Fitzgerald, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.